JME Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1990) 4 231-237    DOI: 10.1677/jme.0.0040231
© 1990 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hurst, R. D.
Right arrow Articles by Morgan, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hurst, R. D.
Right arrow Articles by Morgan, N. G.

Evidence for differential effects of noradrenaline and somatostatin on intracellular messenger systems in rat islets of Langerhans

R. D. Hurst and N. G. Morgan

The mechanisms involved in inhibition of insulin secretion by somatostatin and noradrenaline were compared in order to establish whether the receptors for these agents are coupled to similar effector systems in the pancreatic B cell. Both agents significantly reduced forskolin-induced adenylate cyclase activity in islet homogenates, although noradrenaline was more effective than somatostatin. The capacity of noradrenaline to inhibit insulin secretion was largely unaffected by agents that increase intracellular cyclic AMP, whereas the effect of somatostatin as an inhibitor was markedly reduced under these conditions. Both noradrenaline and somatostatin inhibited the stimulation of insulin secretion induced by K+ depolarization, but different mechanism were involved. Somatostatin significantly inhibited K+-stimulated 45Ca2+ efflux and influx in islets, while noradrenaline exerted only a minor influence on these processes. The data indicate that noradrenaline controls insulin secretion by a mechanism which operates beyond the level of intracellular messenger generation. In contrast, somatostatin exerts at least part of its inhibitory effect on insulin secretion by directly controlling islet cell Ca2+ influx in a manner which may be regulated by cyclic AMP.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Miura and H. Matsui
Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic {beta}-cells
Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1001 - E1009.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. A Smith, L. A Sellers, and P. P A Humphrey
Somatostatin activates two types of inwardly rectifying K+ channels in MIN-6 cells
J. Physiol., April 1, 2001; 532(1): 127 - 142.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Gilligan, G. I. Welsh, A. Flynn, I. Bujalska, T. A. Diggle, R. M. Denton, C. G. Proud, and K. Docherty
Glucose Stimulates the Activity of the Guanine Nucleotide-exchange Factor eIF-2B in Isolated Rat Islets of Langerhans
J. Biol. Chem., January 26, 1996; 271(4): 2121 - 2125.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the Society for Endocrinology.